ZKLJ-02

N/A

Report date: 2025/02/26 13:21:44
NME

Base Information

Drug NameZKLJ-02
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor XII inhibitorsPlasma kallikrein inhibitors
TargetsCoagulation factor XIIPlasma kallikrein
Therapy Area/IndicationsIschemic StrokeCardiovascular DiseasesStroke +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesKunming Longjin Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesYunnan Zhongke Longjin Biological Technology Co Ltd
Inactive CompaniesKunming Longjin Pharmaceutical Co Ltd
Active IndicationsIschemic StrokeStroke
Inactive IndicationsCardiovascular DiseasesNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A